Division of Becton Dickinson & Co.
Latest From BD Technologies
The US Department of Homeland Security National Cybersecurity and Communications Integration Center is warning of potential cybersecurity vulnerabilities in Stryker hospital beds and BD diagnostics equipment.
US FDA hosted a range of device- and IT-industry stakeholders for a two-day event on medical device cybersecurity in pre-market submissions. The first day emphasized securing legacy software, authentication and encryption techniques, and risk assessment models, among other issues
During the week of the ostensibly pivotal EU Summit on Brexit, the UK government has made the EU27 wait for its white paper on proposed post-EU trading arrangements. The UK medtech industry, in turn, is kept waiting on its EU future. But far from remaining idle, manufacturers are focusing on innovation adoption and working with the NHS, where there is a new sense of purpose, and maybe a light at the end of the tunnel.
Global device company Becton Dickinson names a chief scientific officer for greater Asia to enhance R&D in the region, and Chinese maker Simcere hires former GSK R&D China head as its new chief scientific officer. Meanwhile, Takeda names its European Development Center director to lead the R&D efforts in the Americas.
- In Vitro Diagnostics
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Becton Dickinson & Co.
- Senior Management
- Contact Info
Phone: (919) 313-6196
21 Davis Dr.
Research Triangle Park, NC 27709
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.